GIUSEPPE DI BELLA > NEWS > null > null > Bromocriptina e Cabergolina nelle malattie linfoproliferative

 
Bromocriptina e Cabergolina nelle malattie linfoproliferative di S.I.B.O.R. - M.D.B.
 
 
Data: 14/07/2006
Tipologia: MDB - Documentazione
Lingua: Italiano
Anno: 2006
 
 
Descrizione:
PER LEGGERE E SCARICARE IL CAPITOLO SULLA BROMOCRIPTINA E CABERGOLINA, COMPLETO DI BIBLIOGRAFIA E RELATIVI ABSTRACT, CLICCARE QUESTO LINK.
Il file è di 49 pagine in formato PDF e pesa 166 kb.



BIBLIOGRAFIA





Al-Sakkaf, K. A., L. M. Mooney, et al. (2000). "Possible role for protein kinase B in the anti-apoptotic effect of prolactin in rat Nb2 lymphoma cells." J Endocrinol 167(1): 85-92.





Ben-Jonathan, N. and R. Hnasko (2001). "Dopamine as a prolactin (PRL) inhibitor." Endocr Rev 22(6): 724-63.





Ben-Jonathan, N., K. Liby, et al. (2002). "Prolactin as an autocrine/paracrine growth factor in human cancer." Trends Endocrinol Metab 13(6): 245-50.





Bhatavdekar, J., D. Patel, et al. (1994). "Interrelationship of prolactin and its receptor in carcinoma of colon and rectum: a preliminary report." J Surg Oncol 55(4): 246-9.





Bhatavdekar, J. M., D. D. Patel, et al. (1995). "Prognostic value of insulin-like growth factor-1 receptors in patients with colon/rectal cancer: correlation with plasma prolactin." Eur J Surg Oncol 21(1): 23-6.





Bole-Feysot, C., V. Goffin, et al. (1998). "Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice." Endocr Rev 19(3): 225-68.





Buckley, A. R. and D. J. Buckley (2000). "Prolactin regulation of apoptosis-associated gene expression in T cells." Ann N Y Acad Sci 917: 522-33.





Buckley, A. R., C. W. Putnam, et al. (1988). "Prolactin as a mammalian mitogen and tumor promoter." Adv Enzyme Regul 27: 371-91.





Camarillo, I. G., B. E. Linebaugh, et al. (1997). "Differential tyrosyl-phosphorylation of multiple mitogen-activated protein kinase isoforms in response to prolactin in Nb2 lymphoma cells." Proc Soc Exp Biol Med 215(2): 198-202.





Camarillo, I. G. and J. A. Rillema (1998). "Changes in numbers of prolactin receptors during the cell cycle of Nb2 cells." J Endocrinol 159(1): R1-4.





Colao, A., A. di Sarno, et al. (2002). "Dopamine receptor agonists for treating prolactinomas." Expert Opin Investig Drugs 11(6): 787-800.





Dardenne, M., C. de Moraes Mdo, et al. (1994). "Prolactin receptor expression in human hematopoietic tissues analyzed by flow cytofluorometry." Endocrinology 134(5): 2108-14.





Davis, J. A. and D. I. Linzer (1988). "Autocrine stimulation of Nb2 cell proliferation by secreted, but not intracellular, prolactin." Mol Endocrinol 2(8): 740-6.





DiMattia, G. E., B. Gellersen, et al. (1988). "A human B-lymphoblastoid cell line produces prolactin." Endocrinology 122(6): 2508-17.





Ganguli, S., L. Hu, et al. (1996). "Nuclear accumulation of multiple protein kinases during prolactin-induced proliferation of Nb2 rat lymphoma cells." J Cell Physiol 167(2): 251-60.





Goffin, V., N. Binart, et al. (2002). "Prolactin: the new biology of an old hormone." Annu Rev Physiol 64: 47-67.





Gout, P. W., C. T. Beer, et al. (1980). "Prolactin-stimulated growth of cell cultures established from malignant Nb rat lymphomas." Cancer Res 40(7): 2433-6.





Harris, J., P. M. Stanford, et al. (2004). "Prolactin and the prolactin receptor: new targets of an old hormone." Ann Med 36(6): 414-25.





Hooghe, R., S. Merchav, et al. (1998). "A role for growth hormone and prolactin in leukaemia and lymphoma?" Cell Mol Life Sci 54(10): 1095-101.





Janssen, T., F. Darro, et al. (1996). "In vitro characterization of prolactin-induced effects on proliferation in the neoplastic LNCaP, DU145, and PC3 models of the human prostate." Cancer 77(1): 144-9.





Kooijman, R., S. Gerlo, et al. (2000). "Myeloid leukemic cells express and secrete bioactive pituitary-sized 23 kDa prolactin." J Neuroimmunol 110(1-2): 252-8.





Kossiakoff, A. A. (2004). "The structural basis for biological signaling, regulation, and specificity in the growth hormone-prolactin system of hormones and receptors." Adv Protein Chem 68: 147-69.





Krumenacker, J. S., D. J. Buckley, et al. (1998). "Prolactin-regulated apoptosis of Nb2 lymphoma cells: pim-1, bcl-2, and bax expression." Endocrine 9(2): 163-70.





LaVoie, H. A. and R. J. Witorsch (1995). "Investigation of intracellular signals mediating the anti-apoptotic action of prolactin in Nb2 lymphoma cells." Proc Soc Exp Biol Med 209(3): 257-69.





Matera, L. (1996). "Endocrine, paracrine and autocrine actions of prolactin on immune cells." Life Sci 59(8): 599-614.





Matera, L., M. Cutufia, et al. (1997). "Prolactin is an autocrine growth factor for the Jurkat human T-leukemic cell line." J Neuroimmunol 79(1): 12-21.





Matera, L., M. Geuna, et al. (2000). "Expression of prolactin and prolactin receptors by non-Hodgkin's lymphoma cells." Int J Cancer 85(1): 124-30.





Mehta, A. E. and G. Tolis (1979). "Pharmacology of bromocriptine in health and disease." Drugs 17(5): 313-25.





Nishiguchi, Y., H. Hibasami, et al. (1993). "Human promyelocytic cell line HL60 has the specific binding sites for prolactin and its ornithine decarboxylase, DNA synthesis and cellular proliferation are induced by prolactin." Leuk Res 17(8): 633-7.





Nowak, R. A., M. S. Rein, et al. (1993). "Production of prolactin by smooth muscle cells cultured from human uterine fibroid tumors." J Clin Endocrinol Metab 76(5): 1308-13.





O'Neal, K. D., L. A. Schwarz, et al. (1991). "Prolactin receptor gene expression in lymphoid cells." Mol Cell Endocrinol 82(2-3): 127-35.





Pellegrini, I., J. J. Lebrun, et al. (1992). "Expression of prolactin and its receptor in human lymphoid cells." Mol Endocrinol 6(7): 1023-31.





Rains, C. P., H. M. Bryson, et al. (1995). "Cabergoline. A review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinaemia and inhibition of lactation." Drugs 49(2): 255-79.





Todisco, M., P. Casaccia, et al. (2001). "Cyclophosphamide plus somatostatin, bromocriptin, retinoids, melatonin and ACTH in the treatment of low-grade non-Hodgkin's lymphomas at advanced stage: results of a phase II trial." Cancer Biother Radiopharm 16(2): 171-7.





Vonderhaar, B. K. (1998). "Prolactin: the forgotten hormone of human breast cancer." Pharmacol Ther 79(2): 169-78.





Vonderhaar, B. K. (1999). "Prolactin involvement in breast cancer." Endocr Relat Cancer 6(3): 389-404.





Walker, A. M., D. W. Montgomery, et al. (1995). "Prolactin-immunoglobulin G complexes from human serum act as costimulatory ligands causing proliferation of malignant B lymphocytes." Proc Natl Acad Sci U S A 92(8): 3278-82.





Yu-Lee, L. Y. (1990). "Prolactin stimulates transcription of growth-related genes in Nb2 T lymphoma cells." Mol Cell Endocrinol 68(1): 21-8.

Yu, T. X. and J. A. Rillema (2000). "Prolactin stimulation of tyrosyl phosphorylation of Shc proteins in Nb(2) lymphoma cells, but not mammary tissues." Biochim Biophys Acta 1497(1): 89-93.
 
 
 

PER LEGGERE E SCARICARE IL CAPITOLO SULLA BROMOCRIPTINA E CABERGOLINA, COMPLETO DI BIBLIOGRAFIA E RELATIVI ABSTRACT, CLICCARE QUESTO LINK.
Il file è di 49 pagine in formato PDF e pesa 166 kb.



BIBLIOGRAFIA





Al-Sakkaf, K. A., L. M. Mooney, et al. (2000). "Possible role for protein kinase B in the anti-apoptotic effect of prolactin in rat Nb2 lymphoma cells." J Endocrinol 167(1): 85-92.





Ben-Jonathan, N. and R. Hnasko (2001). "Dopamine as a prolactin (PRL) inhibitor." Endocr Rev 22(6): 724-63.





Ben-Jonathan, N., K. Liby, et al. (2002). "Prolactin as an autocrine/paracrine growth factor in human cancer." Trends Endocrinol Metab 13(6): 245-50.





Bhatavdekar, J., D. Patel, et al. (1994). "Interrelationship of prolactin and its receptor in carcinoma of colon and rectum: a preliminary report." J Surg Oncol 55(4): 246-9.





Bhatavdekar, J. M., D. D. Patel, et al. (1995). "Prognostic value of insulin-like growth factor-1 receptors in patients with colon/rectal cancer: correlation with plasma prolactin." Eur J Surg Oncol 21(1): 23-6.





Bole-Feysot, C., V. Goffin, et al. (1998). "Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice." Endocr Rev 19(3): 225-68.





Buckley, A. R. and D. J. Buckley (2000). "Prolactin regulation of apoptosis-associated gene expression in T cells." Ann N Y Acad Sci 917: 522-33.





Buckley, A. R., C. W. Putnam, et al. (1988). "Prolactin as a mammalian mitogen and tumor promoter." Adv Enzyme Regul 27: 371-91.





Camarillo, I. G., B. E. Linebaugh, et al. (1997). "Differential tyrosyl-phosphorylation of multiple mitogen-activated protein kinase isoforms in response to prolactin in Nb2 lymphoma cells." Proc Soc Exp Biol Med 215(2): 198-202.





Camarillo, I. G. and J. A. Rillema (1998). "Changes in numbers of prolactin receptors during the cell cycle of Nb2 cells." J Endocrinol 159(1): R1-4.





Colao, A., A. di Sarno, et al. (2002). "Dopamine receptor agonists for treating prolactinomas." Expert Opin Investig Drugs 11(6): 787-800.





Dardenne, M., C. de Moraes Mdo, et al. (1994). "Prolactin receptor expression in human hematopoietic tissues analyzed by flow cytofluorometry." Endocrinology 134(5): 2108-14.





Davis, J. A. and D. I. Linzer (1988). "Autocrine stimulation of Nb2 cell proliferation by secreted, but not intracellular, prolactin." Mol Endocrinol 2(8): 740-6.





DiMattia, G. E., B. Gellersen, et al. (1988). "A human B-lymphoblastoid cell line produces prolactin." Endocrinology 122(6): 2508-17.





Ganguli, S., L. Hu, et al. (1996). "Nuclear accumulation of multiple protein kinases during prolactin-induced proliferation of Nb2 rat lymphoma cells." J Cell Physiol 167(2): 251-60.





Goffin, V., N. Binart, et al. (2002). "Prolactin: the new biology of an old hormone." Annu Rev Physiol 64: 47-67.





Gout, P. W., C. T. Beer, et al. (1980). "Prolactin-stimulated growth of cell cultures established from malignant Nb rat lymphomas." Cancer Res 40(7): 2433-6.





Harris, J., P. M. Stanford, et al. (2004). "Prolactin and the prolactin receptor: new targets of an old hormone." Ann Med 36(6): 414-25.





Hooghe, R., S. Merchav, et al. (1998). "A role for growth hormone and prolactin in leukaemia and lymphoma?" Cell Mol Life Sci 54(10): 1095-101.





Janssen, T., F. Darro, et al. (1996). "In vitro characterization of prolactin-induced effects on proliferation in the neoplastic LNCaP, DU145, and PC3 models of the human prostate." Cancer 77(1): 144-9.





Kooijman, R., S. Gerlo, et al. (2000). "Myeloid leukemic cells express and secrete bioactive pituitary-sized 23 kDa prolactin." J Neuroimmunol 110(1-2): 252-8.





Kossiakoff, A. A. (2004). "The structural basis for biological signaling, regulation, and specificity in the growth hormone-prolactin system of hormones and receptors." Adv Protein Chem 68: 147-69.





Krumenacker, J. S., D. J. Buckley, et al. (1998). "Prolactin-regulated apoptosis of Nb2 lymphoma cells: pim-1, bcl-2, and bax expression." Endocrine 9(2): 163-70.





LaVoie, H. A. and R. J. Witorsch (1995). "Investigation of intracellular signals mediating the anti-apoptotic action of prolactin in Nb2 lymphoma cells." Proc Soc Exp Biol Med 209(3): 257-69.





Matera, L. (1996). "Endocrine, paracrine and autocrine actions of prolactin on immune cells." Life Sci 59(8): 599-614.





Matera, L., M. Cutufia, et al. (1997). "Prolactin is an autocrine growth factor for the Jurkat human T-leukemic cell line." J Neuroimmunol 79(1): 12-21.





Matera, L., M. Geuna, et al. (2000). "Expression of prolactin and prolactin receptors by non-Hodgkin's lymphoma cells." Int J Cancer 85(1): 124-30.





Mehta, A. E. and G. Tolis (1979). "Pharmacology of bromocriptine in health and disease." Drugs 17(5): 313-25.





Nishiguchi, Y., H. Hibasami, et al. (1993). "Human promyelocytic cell line HL60 has the specific binding sites for prolactin and its ornithine decarboxylase, DNA synthesis and cellular proliferation are induced by prolactin." Leuk Res 17(8): 633-7.





Nowak, R. A., M. S. Rein, et al. (1993). "Production of prolactin by smooth muscle cells cultured from human uterine fibroid tumors." J Clin Endocrinol Metab 76(5): 1308-13.





O'Neal, K. D., L. A. Schwarz, et al. (1991). "Prolactin receptor gene expression in lymphoid cells." Mol Cell Endocrinol 82(2-3): 127-35.





Pellegrini, I., J. J. Lebrun, et al. (1992). "Expression of prolactin and its receptor in human lymphoid cells." Mol Endocrinol 6(7): 1023-31.





Rains, C. P., H. M. Bryson, et al. (1995). "Cabergoline. A review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinaemia and inhibition of lactation." Drugs 49(2): 255-79.





Todisco, M., P. Casaccia, et al. (2001). "Cyclophosphamide plus somatostatin, bromocriptin, retinoids, melatonin and ACTH in the treatment of low-grade non-Hodgkin's lymphomas at advanced stage: results of a phase II trial." Cancer Biother Radiopharm 16(2): 171-7.





Vonderhaar, B. K. (1998). "Prolactin: the forgotten hormone of human breast cancer." Pharmacol Ther 79(2): 169-78.





Vonderhaar, B. K. (1999). "Prolactin involvement in breast cancer." Endocr Relat Cancer 6(3): 389-404.





Walker, A. M., D. W. Montgomery, et al. (1995). "Prolactin-immunoglobulin G complexes from human serum act as costimulatory ligands causing proliferation of malignant B lymphocytes." Proc Natl Acad Sci U S A 92(8): 3278-82.





Yu-Lee, L. Y. (1990). "Prolactin stimulates transcription of growth-related genes in Nb2 T lymphoma cells." Mol Cell Endocrinol 68(1): 21-8.

Yu, T. X. and J. A. Rillema (2000). "Prolactin stimulation of tyrosyl phosphorylation of Shc proteins in Nb(2) lymphoma cells, but not mammary tissues." Biochim Biophys Acta 1497(1): 89-93.
 
 
 

 

Documento Allegato

Stampa